The 45 rating InvestorsObserver gives to Bausch Health Companies Inc (BHC) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 76 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, BHC’s 45 overall rating means the stock scores better than 45 percent of all stocks.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Bausch Health Companies Inc Stock Today?
Bausch Health Companies Inc (BHC) stock is higher by 2.2% while the S&P 500 is lower by -0.07% as of 11:55 AM on Wednesday, Oct 21. BHC is up $0.38 from the previous closing price of $17.02 on volume of 1,399,301 shares. Over the past year the S&P 500 is up 14.84% while BHC is lower by -22.94%. BHC lost -$5.78 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Bausch Health Companies Inc (BHC) Stock.
